CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Additionally, GLI1, a downstream target of Hh signaling, was significantly upregulated in CD34+ chronic phase (CP) CML cells compared to in normal CD34+ hematopoietic cells [145].